Although capable of reducing trivial mistakes, AI coding copilots leave enterprises at risk of increased insecure coding ...
In this article, we benchmark Escape against other DAST tools. Focusing on Gin & Juice Shop, we compare results across ...
In less than half a year, a cybersecurity startup co-founded by Ahmed Allam has gone from late-night brainstorming sessions ...
AI browsers from Microsoft, OpenAI and Perplexity can fall for scams faster than humans, completing fraudulent purchases and ...
From unpatched cars to hijacked clouds, this week's Threatsday headlines remind us of one thing — no corner of technology is ...
CVEs & Vulnerabilities of September 2025 reveal a wave of high-impact flaws that security teams cannot afford to ignore. From unauthenticated exploits in FreePBX to privilege escalation in Android and ...
The rapid integration of Generative AI into business processes is undeniable. However, this speed has often left security as ...
Vacuoles, E1 enzyme, X-linked, autoinflammatory, and somatic (VEXAS) syndrome is a newly identified disorder caused by an ...
Stockhead on MSN
Dr Boreham’s Crucible: A ‘clear route to market’ could emerge beyond this rocky share price road
This biotech's recent stroke drug trial results appeared to disappoint investors, but there was plenty of positive nuance in the details.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback